VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement - The Manila Times
Voyager Acquisition→VERAXA Biotech
May 28, 2026
DePuy Synthes has completed the acquisition of MinMaxMedical, a medical devices business in California, for $270M. MinMaxMedical provides radiofrequency tracking technology for orthopedic surgery, branded as Gemtrack, aimed at real-time procedural navigation for joint reconstruction. DePuy Synthes acquisitions focus on image-guided and robotic-assisted orthopedic procedures across shoulder, hip, and knee, and it plans to integrate Gemtrack with its Velys platform to improve continuous tracking versus infrared camera systems. The add on acquisition is a strategic acquisition by J&J’s orthopedics unit, with selective rights to develop, manufacture, and commercialize the technology. Healthcare M&A deal terms were announced, with total deal value cited up to $650M and a market timeline dependent on development and regulatory milestones.
Voyager Acquisition→VERAXA Biotech
May 28, 2026
VERAXA Biotech
May 28, 2026
Carriage Services→McCammon Ammons Click Funeral Home
May 27, 2026
Olympus→BioProtect
May 27, 2026
Kaos Capital→BioRestorative Therapies
May 27, 2026